Category Archives: News
Phase II Study Shows No Improvement in PFS with Addition of Pertuzumab
A study of 149 women with platinum sensitive ovarian cancer, half treated with carboplatin and paclitaxel or gemcitabine, half with that treatment plus pertuzumab, showed that the addition of pertuzumab … Continue reading
Farletuzumab Trial Fails to Show Increase in PFS
Pap Test for Ovarian Cancer?
A small study of 46 women showed that examining cells on the cervix can help identify ovarian and uterine cancers. In this study, DNA analysis detected 41% of ovarian cancer … Continue reading
Screening for Familial Ovarian Cancer
More than 3,000 women with a high risk of developing ovarian cancer were enrolled in a screening study. These women were screened every year with a CA-125 blood test and … Continue reading
BRCA Mutation Does Not Have Effect on Long Term Survival
A study of 1,626 women with ovarian cancer showed that women with a BRCA mutation had increased survival rates at three years after diagnosis, but had the same rates of … Continue reading
Metformin May Increase Survival For Women With Ovarian Cancer
Metformin, a drug used to treat diabetes and polycystic ovarian syndrome (PCOS), may increase survival for women with ovarian cancer. A study of 239 women with ovarian cancer divided them … Continue reading
Study Suggests Screening Useful for High Risk Women
A study of 3,500 women at high risk of developing ovarian/fallopian cancer were screened annually for approximately three years with the CA-125 blood test and transvaginal ultrasound. In this population, … Continue reading
Hospice Reimbursement May Disincentivize Care for Expensive Patients
A study by the Commonwealth Foundation found that patients with expensive treatment, such as palliative chemotherapy, were more likely to be turned away from hospice facilities. Some findings include The … Continue reading
Supreme Court to Hear Gene Patent Case
The Supreme Court of the United States will hear arguments in a case seeking to invalidate the patents on the BRCA1 and BRCA2 mutations. The patent-holder, Myriad Laboratories, owns patents … Continue reading
Dogs Sniff Ovarian Cancer
Based on funding from the Congressionally Directed Medical Research Programs, the cancer-sniffing dog training and studies continue. Read the full article here Ensure that Congress supports the Congressionally Directed Medical … Continue reading
EU Reviews Folate Receptor Drug
The European Union will review vintafolide, a folate receptor drug for ovarian cancer, made by Endocyte/Merck. The regulatory agency should make a decision in the first half of 2013. Read … Continue reading
Physiological Evidence of “Cancer Brain” Found
Using PET/CT scans, researchers looked at the brain function of 128 breast cancer patients. The study aimed to show that PET/CT is a useful tool to measure the presence of … Continue reading
